Chemical & Material
Edoxaban Tosylate API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
- Oct 12, 24
- ID: 163183
- Pages: 96
- Figures: 208
- Views: 6
The global market for Edoxaban Tosylate API was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Edoxaban Tosylate API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Edoxaban Tosylate API by region & country, by Type, and by Application.
The Edoxaban Tosylate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edoxaban Tosylate API.
Market Segmentation
By Company
MOREPEN LABORATORIES LTD
ZYDUS LIFESCIENCES LTD
HONOUR LAB LTD
MSN LIFE SCIENCES PRIVATE LTD
ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
Simcere Pharmaceutical
Segment by Type:
Purity≥98%
Purity<98%
Segment by Application
Tablet
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Edoxaban Tosylate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Edoxaban Tosylate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Edoxaban Tosylate API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Edoxaban Tosylate API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Edoxaban Tosylate API by region & country, by Type, and by Application.
The Edoxaban Tosylate API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Edoxaban Tosylate API.
Market Segmentation
By Company
MOREPEN LABORATORIES LTD
ZYDUS LIFESCIENCES LTD
HONOUR LAB LTD
MSN LIFE SCIENCES PRIVATE LTD
ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
Simcere Pharmaceutical
Segment by Type:
Purity≥98%
Purity<98%
Segment by Application
Tablet
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Edoxaban Tosylate API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Edoxaban Tosylate API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Edoxaban Tosylate API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Edoxaban Tosylate API Product Introduction
1.2 Global Edoxaban Tosylate API Market Size Forecast
1.2.1 Global Edoxaban Tosylate API Sales Value (2019-2030)
1.2.2 Global Edoxaban Tosylate API Sales Volume (2019-2030)
1.2.3 Global Edoxaban Tosylate API Sales Price (2019-2030)
1.3 Edoxaban Tosylate API Market Trends & Drivers
1.3.1 Edoxaban Tosylate API Industry Trends
1.3.2 Edoxaban Tosylate API Market Drivers & Opportunity
1.3.3 Edoxaban Tosylate API Market Challenges
1.3.4 Edoxaban Tosylate API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Edoxaban Tosylate API Players Revenue Ranking (2023)
2.2 Global Edoxaban Tosylate API Revenue by Company (2019-2024)
2.3 Global Edoxaban Tosylate API Players Sales Volume Ranking (2023)
2.4 Global Edoxaban Tosylate API Sales Volume by Company Players (2019-2024)
2.5 Global Edoxaban Tosylate API Average Price by Company (2019-2024)
2.6 Key Manufacturers Edoxaban Tosylate API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Edoxaban Tosylate API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Edoxaban Tosylate API
2.9 Edoxaban Tosylate API Market Competitive Analysis
2.9.1 Edoxaban Tosylate API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Edoxaban Tosylate API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edoxaban Tosylate API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity≥98%
3.1.2 Purity<98%
3.2 Global Edoxaban Tosylate API Sales Value by Type
3.2.1 Global Edoxaban Tosylate API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Edoxaban Tosylate API Sales Value, by Type (2019-2030)
3.2.3 Global Edoxaban Tosylate API Sales Value, by Type (%) (2019-2030)
3.3 Global Edoxaban Tosylate API Sales Volume by Type
3.3.1 Global Edoxaban Tosylate API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Edoxaban Tosylate API Sales Volume, by Type (2019-2030)
3.3.3 Global Edoxaban Tosylate API Sales Volume, by Type (%) (2019-2030)
3.4 Global Edoxaban Tosylate API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Others
4.2 Global Edoxaban Tosylate API Sales Value by Application
4.2.1 Global Edoxaban Tosylate API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Edoxaban Tosylate API Sales Value, by Application (2019-2030)
4.2.3 Global Edoxaban Tosylate API Sales Value, by Application (%) (2019-2030)
4.3 Global Edoxaban Tosylate API Sales Volume by Application
4.3.1 Global Edoxaban Tosylate API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Edoxaban Tosylate API Sales Volume, by Application (2019-2030)
4.3.3 Global Edoxaban Tosylate API Sales Volume, by Application (%) (2019-2030)
4.4 Global Edoxaban Tosylate API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Edoxaban Tosylate API Sales Value by Region
5.1.1 Global Edoxaban Tosylate API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Edoxaban Tosylate API Sales Value by Region (2019-2024)
5.1.3 Global Edoxaban Tosylate API Sales Value by Region (2025-2030)
5.1.4 Global Edoxaban Tosylate API Sales Value by Region (%), (2019-2030)
5.2 Global Edoxaban Tosylate API Sales Volume by Region
5.2.1 Global Edoxaban Tosylate API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Edoxaban Tosylate API Sales Volume by Region (2019-2024)
5.2.3 Global Edoxaban Tosylate API Sales Volume by Region (2025-2030)
5.2.4 Global Edoxaban Tosylate API Sales Volume by Region (%), (2019-2030)
5.3 Global Edoxaban Tosylate API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Edoxaban Tosylate API Sales Value, 2019-2030
5.4.2 North America Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Edoxaban Tosylate API Sales Value, 2019-2030
5.5.2 Europe Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Edoxaban Tosylate API Sales Value, 2019-2030
5.6.2 Asia Pacific Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Edoxaban Tosylate API Sales Value, 2019-2030
5.7.2 South America Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Edoxaban Tosylate API Sales Value, 2019-2030
5.8.2 Middle East & Africa Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Edoxaban Tosylate API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Edoxaban Tosylate API Sales Value
6.2.1 Key Countries/Regions Edoxaban Tosylate API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Edoxaban Tosylate API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Edoxaban Tosylate API Sales Value, 2019-2030
6.3.2 United States Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Edoxaban Tosylate API Sales Value, 2019-2030
6.4.2 Europe Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Edoxaban Tosylate API Sales Value, 2019-2030
6.5.2 China Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Edoxaban Tosylate API Sales Value, 2019-2030
6.6.2 Japan Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Edoxaban Tosylate API Sales Value, 2019-2030
6.7.2 South Korea Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Edoxaban Tosylate API Sales Value, 2019-2030
6.8.2 Southeast Asia Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Edoxaban Tosylate API Sales Value, 2019-2030
6.9.2 India Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 MOREPEN LABORATORIES LTD
7.1.1 MOREPEN LABORATORIES LTD Company Information
7.1.2 MOREPEN LABORATORIES LTD Introduction and Business Overview
7.1.3 MOREPEN LABORATORIES LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 MOREPEN LABORATORIES LTD Edoxaban Tosylate API Product Offerings
7.1.5 MOREPEN LABORATORIES LTD Recent Development
7.2 ZYDUS LIFESCIENCES LTD
7.2.1 ZYDUS LIFESCIENCES LTD Company Information
7.2.2 ZYDUS LIFESCIENCES LTD Introduction and Business Overview
7.2.3 ZYDUS LIFESCIENCES LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ZYDUS LIFESCIENCES LTD Edoxaban Tosylate API Product Offerings
7.2.5 ZYDUS LIFESCIENCES LTD Recent Development
7.3 HONOUR LAB LTD
7.3.1 HONOUR LAB LTD Company Information
7.3.2 HONOUR LAB LTD Introduction and Business Overview
7.3.3 HONOUR LAB LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 HONOUR LAB LTD Edoxaban Tosylate API Product Offerings
7.3.5 HONOUR LAB LTD Recent Development
7.4 MSN LIFE SCIENCES PRIVATE LTD
7.4.1 MSN LIFE SCIENCES PRIVATE LTD Company Information
7.4.2 MSN LIFE SCIENCES PRIVATE LTD Introduction and Business Overview
7.4.3 MSN LIFE SCIENCES PRIVATE LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 MSN LIFE SCIENCES PRIVATE LTD Edoxaban Tosylate API Product Offerings
7.4.5 MSN LIFE SCIENCES PRIVATE LTD Recent Development
7.5 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
7.5.1 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information
7.5.2 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Introduction and Business Overview
7.5.3 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Edoxaban Tosylate API Product Offerings
7.5.5 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Development
7.6 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
7.6.1 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information
7.6.2 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Introduction and Business Overview
7.6.3 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Edoxaban Tosylate API Product Offerings
7.6.5 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Development
7.7 Simcere Pharmaceutical
7.7.1 Simcere Pharmaceutical Company Information
7.7.2 Simcere Pharmaceutical Introduction and Business Overview
7.7.3 Simcere Pharmaceutical Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Simcere Pharmaceutical Edoxaban Tosylate API Product Offerings
7.7.5 Simcere Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Edoxaban Tosylate API Industrial Chain
8.2 Edoxaban Tosylate API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Edoxaban Tosylate API Sales Model
8.5.2 Sales Channel
8.5.3 Edoxaban Tosylate API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
1.1 Edoxaban Tosylate API Product Introduction
1.2 Global Edoxaban Tosylate API Market Size Forecast
1.2.1 Global Edoxaban Tosylate API Sales Value (2019-2030)
1.2.2 Global Edoxaban Tosylate API Sales Volume (2019-2030)
1.2.3 Global Edoxaban Tosylate API Sales Price (2019-2030)
1.3 Edoxaban Tosylate API Market Trends & Drivers
1.3.1 Edoxaban Tosylate API Industry Trends
1.3.2 Edoxaban Tosylate API Market Drivers & Opportunity
1.3.3 Edoxaban Tosylate API Market Challenges
1.3.4 Edoxaban Tosylate API Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Edoxaban Tosylate API Players Revenue Ranking (2023)
2.2 Global Edoxaban Tosylate API Revenue by Company (2019-2024)
2.3 Global Edoxaban Tosylate API Players Sales Volume Ranking (2023)
2.4 Global Edoxaban Tosylate API Sales Volume by Company Players (2019-2024)
2.5 Global Edoxaban Tosylate API Average Price by Company (2019-2024)
2.6 Key Manufacturers Edoxaban Tosylate API Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Edoxaban Tosylate API Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Edoxaban Tosylate API
2.9 Edoxaban Tosylate API Market Competitive Analysis
2.9.1 Edoxaban Tosylate API Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Edoxaban Tosylate API Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edoxaban Tosylate API as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Purity≥98%
3.1.2 Purity<98%
3.2 Global Edoxaban Tosylate API Sales Value by Type
3.2.1 Global Edoxaban Tosylate API Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Edoxaban Tosylate API Sales Value, by Type (2019-2030)
3.2.3 Global Edoxaban Tosylate API Sales Value, by Type (%) (2019-2030)
3.3 Global Edoxaban Tosylate API Sales Volume by Type
3.3.1 Global Edoxaban Tosylate API Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Edoxaban Tosylate API Sales Volume, by Type (2019-2030)
3.3.3 Global Edoxaban Tosylate API Sales Volume, by Type (%) (2019-2030)
3.4 Global Edoxaban Tosylate API Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Tablet
4.1.2 Others
4.2 Global Edoxaban Tosylate API Sales Value by Application
4.2.1 Global Edoxaban Tosylate API Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Edoxaban Tosylate API Sales Value, by Application (2019-2030)
4.2.3 Global Edoxaban Tosylate API Sales Value, by Application (%) (2019-2030)
4.3 Global Edoxaban Tosylate API Sales Volume by Application
4.3.1 Global Edoxaban Tosylate API Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Edoxaban Tosylate API Sales Volume, by Application (2019-2030)
4.3.3 Global Edoxaban Tosylate API Sales Volume, by Application (%) (2019-2030)
4.4 Global Edoxaban Tosylate API Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Edoxaban Tosylate API Sales Value by Region
5.1.1 Global Edoxaban Tosylate API Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Edoxaban Tosylate API Sales Value by Region (2019-2024)
5.1.3 Global Edoxaban Tosylate API Sales Value by Region (2025-2030)
5.1.4 Global Edoxaban Tosylate API Sales Value by Region (%), (2019-2030)
5.2 Global Edoxaban Tosylate API Sales Volume by Region
5.2.1 Global Edoxaban Tosylate API Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Edoxaban Tosylate API Sales Volume by Region (2019-2024)
5.2.3 Global Edoxaban Tosylate API Sales Volume by Region (2025-2030)
5.2.4 Global Edoxaban Tosylate API Sales Volume by Region (%), (2019-2030)
5.3 Global Edoxaban Tosylate API Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Edoxaban Tosylate API Sales Value, 2019-2030
5.4.2 North America Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Edoxaban Tosylate API Sales Value, 2019-2030
5.5.2 Europe Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Edoxaban Tosylate API Sales Value, 2019-2030
5.6.2 Asia Pacific Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Edoxaban Tosylate API Sales Value, 2019-2030
5.7.2 South America Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Edoxaban Tosylate API Sales Value, 2019-2030
5.8.2 Middle East & Africa Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Edoxaban Tosylate API Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Edoxaban Tosylate API Sales Value
6.2.1 Key Countries/Regions Edoxaban Tosylate API Sales Value, 2019-2030
6.2.2 Key Countries/Regions Edoxaban Tosylate API Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Edoxaban Tosylate API Sales Value, 2019-2030
6.3.2 United States Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Edoxaban Tosylate API Sales Value, 2019-2030
6.4.2 Europe Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Edoxaban Tosylate API Sales Value, 2019-2030
6.5.2 China Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.5.3 China Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Edoxaban Tosylate API Sales Value, 2019-2030
6.6.2 Japan Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Edoxaban Tosylate API Sales Value, 2019-2030
6.7.2 South Korea Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Edoxaban Tosylate API Sales Value, 2019-2030
6.8.2 Southeast Asia Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Edoxaban Tosylate API Sales Value, 2019-2030
6.9.2 India Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
6.9.3 India Edoxaban Tosylate API Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 MOREPEN LABORATORIES LTD
7.1.1 MOREPEN LABORATORIES LTD Company Information
7.1.2 MOREPEN LABORATORIES LTD Introduction and Business Overview
7.1.3 MOREPEN LABORATORIES LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.1.4 MOREPEN LABORATORIES LTD Edoxaban Tosylate API Product Offerings
7.1.5 MOREPEN LABORATORIES LTD Recent Development
7.2 ZYDUS LIFESCIENCES LTD
7.2.1 ZYDUS LIFESCIENCES LTD Company Information
7.2.2 ZYDUS LIFESCIENCES LTD Introduction and Business Overview
7.2.3 ZYDUS LIFESCIENCES LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.2.4 ZYDUS LIFESCIENCES LTD Edoxaban Tosylate API Product Offerings
7.2.5 ZYDUS LIFESCIENCES LTD Recent Development
7.3 HONOUR LAB LTD
7.3.1 HONOUR LAB LTD Company Information
7.3.2 HONOUR LAB LTD Introduction and Business Overview
7.3.3 HONOUR LAB LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.3.4 HONOUR LAB LTD Edoxaban Tosylate API Product Offerings
7.3.5 HONOUR LAB LTD Recent Development
7.4 MSN LIFE SCIENCES PRIVATE LTD
7.4.1 MSN LIFE SCIENCES PRIVATE LTD Company Information
7.4.2 MSN LIFE SCIENCES PRIVATE LTD Introduction and Business Overview
7.4.3 MSN LIFE SCIENCES PRIVATE LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.4.4 MSN LIFE SCIENCES PRIVATE LTD Edoxaban Tosylate API Product Offerings
7.4.5 MSN LIFE SCIENCES PRIVATE LTD Recent Development
7.5 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD
7.5.1 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information
7.5.2 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Introduction and Business Overview
7.5.3 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.5.4 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Edoxaban Tosylate API Product Offerings
7.5.5 ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Development
7.6 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD
7.6.1 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information
7.6.2 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Introduction and Business Overview
7.6.3 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.6.4 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Edoxaban Tosylate API Product Offerings
7.6.5 SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Development
7.7 Simcere Pharmaceutical
7.7.1 Simcere Pharmaceutical Company Information
7.7.2 Simcere Pharmaceutical Introduction and Business Overview
7.7.3 Simcere Pharmaceutical Edoxaban Tosylate API Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Simcere Pharmaceutical Edoxaban Tosylate API Product Offerings
7.7.5 Simcere Pharmaceutical Recent Development
8 Industry Chain Analysis
8.1 Edoxaban Tosylate API Industrial Chain
8.2 Edoxaban Tosylate API Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Edoxaban Tosylate API Sales Model
8.5.2 Sales Channel
8.5.3 Edoxaban Tosylate API Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Edoxaban Tosylate API Market Trends
Table 2. Edoxaban Tosylate API Market Drivers & Opportunity
Table 3. Edoxaban Tosylate API Market Challenges
Table 4. Edoxaban Tosylate API Market Restraints
Table 5. Global Edoxaban Tosylate API Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Edoxaban Tosylate API Revenue Market Share by Company (2019-2024)
Table 7. Global Edoxaban Tosylate API Sales Volume by Company (2019-2024) & (Tons)
Table 8. Global Edoxaban Tosylate API Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Edoxaban Tosylate API Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Edoxaban Tosylate API Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Edoxaban Tosylate API Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Edoxaban Tosylate API
Table 13. Global Edoxaban Tosylate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edoxaban Tosylate API as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Edoxaban Tosylate API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Edoxaban Tosylate API Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Edoxaban Tosylate API Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Edoxaban Tosylate API Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Edoxaban Tosylate API Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Edoxaban Tosylate API Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Edoxaban Tosylate API Sales Volume by Type (2019-2024) & (Tons)
Table 23. Global Edoxaban Tosylate API Sales Volume by Type (2025-2030) & (Tons)
Table 24. Global Edoxaban Tosylate API Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Edoxaban Tosylate API Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Edoxaban Tosylate API Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Edoxaban Tosylate API Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Edoxaban Tosylate API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Edoxaban Tosylate API Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Edoxaban Tosylate API Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Edoxaban Tosylate API Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Edoxaban Tosylate API Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Edoxaban Tosylate API Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Edoxaban Tosylate API Sales Volume by Application (2019-2024) & (Tons)
Table 35. Global Edoxaban Tosylate API Sales Volume by Application (2025-2030) & (Tons)
Table 36. Global Edoxaban Tosylate API Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Edoxaban Tosylate API Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Edoxaban Tosylate API Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Edoxaban Tosylate API Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Edoxaban Tosylate API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Edoxaban Tosylate API Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Edoxaban Tosylate API Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Edoxaban Tosylate API Sales Value by Region (2019-2024) & (%)
Table 44. Global Edoxaban Tosylate API Sales Value by Region (2025-2030) & (%)
Table 45. Global Edoxaban Tosylate API Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
Table 46. Global Edoxaban Tosylate API Sales Volume by Region (2019-2024) & (Tons)
Table 47. Global Edoxaban Tosylate API Sales Volume by Region (2025-2030) & (Tons)
Table 48. Global Edoxaban Tosylate API Sales Volume by Region (2019-2024) & (%)
Table 49. Global Edoxaban Tosylate API Sales Volume by Region (2025-2030) & (%)
Table 50. Global Edoxaban Tosylate API Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Edoxaban Tosylate API Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Edoxaban Tosylate API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Edoxaban Tosylate API Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Edoxaban Tosylate API Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Edoxaban Tosylate API Sales Volume, (2019-2024) & (Tons)
Table 56. Key Countries/Regions Edoxaban Tosylate API Sales Volume, (2025-2030) & (Tons)
Table 57. MOREPEN LABORATORIES LTD Company Information
Table 58. MOREPEN LABORATORIES LTD Introduction and Business Overview
Table 59. MOREPEN LABORATORIES LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. MOREPEN LABORATORIES LTD Edoxaban Tosylate API Product Offerings
Table 61. MOREPEN LABORATORIES LTD Recent Development
Table 62. ZYDUS LIFESCIENCES LTD Company Information
Table 63. ZYDUS LIFESCIENCES LTD Introduction and Business Overview
Table 64. ZYDUS LIFESCIENCES LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. ZYDUS LIFESCIENCES LTD Edoxaban Tosylate API Product Offerings
Table 66. ZYDUS LIFESCIENCES LTD Recent Development
Table 67. HONOUR LAB LTD Company Information
Table 68. HONOUR LAB LTD Introduction and Business Overview
Table 69. HONOUR LAB LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. HONOUR LAB LTD Edoxaban Tosylate API Product Offerings
Table 71. HONOUR LAB LTD Recent Development
Table 72. MSN LIFE SCIENCES PRIVATE LTD Company Information
Table 73. MSN LIFE SCIENCES PRIVATE LTD Introduction and Business Overview
Table 74. MSN LIFE SCIENCES PRIVATE LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. MSN LIFE SCIENCES PRIVATE LTD Edoxaban Tosylate API Product Offerings
Table 76. MSN LIFE SCIENCES PRIVATE LTD Recent Development
Table 77. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information
Table 78. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Introduction and Business Overview
Table 79. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Edoxaban Tosylate API Product Offerings
Table 81. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Development
Table 82. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information
Table 83. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 84. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Edoxaban Tosylate API Product Offerings
Table 86. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Development
Table 87. Simcere Pharmaceutical Company Information
Table 88. Simcere Pharmaceutical Introduction and Business Overview
Table 89. Simcere Pharmaceutical Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Simcere Pharmaceutical Edoxaban Tosylate API Product Offerings
Table 91. Simcere Pharmaceutical Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Edoxaban Tosylate API Downstream Customers
Table 95. Edoxaban Tosylate API Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Edoxaban Tosylate API Product Picture
Figure 2. Global Edoxaban Tosylate API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Edoxaban Tosylate API Sales Volume (2019-2030) & (Tons)
Figure 5. Global Edoxaban Tosylate API Sales Price (2019-2030) & (US$/Ton)
Figure 6. Edoxaban Tosylate API Report Years Considered
Figure 7. Global Edoxaban Tosylate API Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Edoxaban Tosylate API Players Sales Volume Ranking (2023) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Edoxaban Tosylate API Revenue in 2023
Figure 10. Edoxaban Tosylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Purity≥98% Picture
Figure 12. Purity<98% Picture
Figure 13. Global Edoxaban Tosylate API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Edoxaban Tosylate API Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Edoxaban Tosylate API Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 16. Global Edoxaban Tosylate API Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Edoxaban Tosylate API Price by Type (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Tablet
Figure 19. Product Picture of Others
Figure 20. Global Edoxaban Tosylate API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Edoxaban Tosylate API Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Edoxaban Tosylate API Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 23. Global Edoxaban Tosylate API Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Edoxaban Tosylate API Price by Application (2019-2030) & (US$/Ton)
Figure 25. North America Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Edoxaban Tosylate API Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Edoxaban Tosylate API Sales Volume (%), (2019-2030)
Figure 37. United States Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 43. China Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 45. China Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 55. India Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 57. India Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 58. Edoxaban Tosylate API Industrial Chain
Figure 59. Edoxaban Tosylate API Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Edoxaban Tosylate API Market Trends
Table 2. Edoxaban Tosylate API Market Drivers & Opportunity
Table 3. Edoxaban Tosylate API Market Challenges
Table 4. Edoxaban Tosylate API Market Restraints
Table 5. Global Edoxaban Tosylate API Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Edoxaban Tosylate API Revenue Market Share by Company (2019-2024)
Table 7. Global Edoxaban Tosylate API Sales Volume by Company (2019-2024) & (Tons)
Table 8. Global Edoxaban Tosylate API Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Edoxaban Tosylate API Price by Company (2019-2024) & (US$/Ton)
Table 10. Key Manufacturers Edoxaban Tosylate API Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Edoxaban Tosylate API Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Edoxaban Tosylate API
Table 13. Global Edoxaban Tosylate API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Edoxaban Tosylate API as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Edoxaban Tosylate API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Edoxaban Tosylate API Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Edoxaban Tosylate API Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Edoxaban Tosylate API Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Edoxaban Tosylate API Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Edoxaban Tosylate API Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
Table 22. Global Edoxaban Tosylate API Sales Volume by Type (2019-2024) & (Tons)
Table 23. Global Edoxaban Tosylate API Sales Volume by Type (2025-2030) & (Tons)
Table 24. Global Edoxaban Tosylate API Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Edoxaban Tosylate API Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Edoxaban Tosylate API Price by Type (2019-2024) & (US$/Ton)
Table 27. Global Edoxaban Tosylate API Price by Type (2025-2030) & (US$/Ton)
Table 28. Global Edoxaban Tosylate API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Edoxaban Tosylate API Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Edoxaban Tosylate API Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Edoxaban Tosylate API Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Edoxaban Tosylate API Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Edoxaban Tosylate API Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
Table 34. Global Edoxaban Tosylate API Sales Volume by Application (2019-2024) & (Tons)
Table 35. Global Edoxaban Tosylate API Sales Volume by Application (2025-2030) & (Tons)
Table 36. Global Edoxaban Tosylate API Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Edoxaban Tosylate API Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Edoxaban Tosylate API Price by Application (2019-2024) & (US$/Ton)
Table 39. Global Edoxaban Tosylate API Price by Application (2025-2030) & (US$/Ton)
Table 40. Global Edoxaban Tosylate API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Edoxaban Tosylate API Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Edoxaban Tosylate API Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Edoxaban Tosylate API Sales Value by Region (2019-2024) & (%)
Table 44. Global Edoxaban Tosylate API Sales Value by Region (2025-2030) & (%)
Table 45. Global Edoxaban Tosylate API Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
Table 46. Global Edoxaban Tosylate API Sales Volume by Region (2019-2024) & (Tons)
Table 47. Global Edoxaban Tosylate API Sales Volume by Region (2025-2030) & (Tons)
Table 48. Global Edoxaban Tosylate API Sales Volume by Region (2019-2024) & (%)
Table 49. Global Edoxaban Tosylate API Sales Volume by Region (2025-2030) & (%)
Table 50. Global Edoxaban Tosylate API Average Price by Region (2019-2024) & (US$/Ton)
Table 51. Global Edoxaban Tosylate API Average Price by Region (2025-2030) & (US$/Ton)
Table 52. Key Countries/Regions Edoxaban Tosylate API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Edoxaban Tosylate API Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Edoxaban Tosylate API Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Edoxaban Tosylate API Sales Volume, (2019-2024) & (Tons)
Table 56. Key Countries/Regions Edoxaban Tosylate API Sales Volume, (2025-2030) & (Tons)
Table 57. MOREPEN LABORATORIES LTD Company Information
Table 58. MOREPEN LABORATORIES LTD Introduction and Business Overview
Table 59. MOREPEN LABORATORIES LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 60. MOREPEN LABORATORIES LTD Edoxaban Tosylate API Product Offerings
Table 61. MOREPEN LABORATORIES LTD Recent Development
Table 62. ZYDUS LIFESCIENCES LTD Company Information
Table 63. ZYDUS LIFESCIENCES LTD Introduction and Business Overview
Table 64. ZYDUS LIFESCIENCES LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 65. ZYDUS LIFESCIENCES LTD Edoxaban Tosylate API Product Offerings
Table 66. ZYDUS LIFESCIENCES LTD Recent Development
Table 67. HONOUR LAB LTD Company Information
Table 68. HONOUR LAB LTD Introduction and Business Overview
Table 69. HONOUR LAB LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 70. HONOUR LAB LTD Edoxaban Tosylate API Product Offerings
Table 71. HONOUR LAB LTD Recent Development
Table 72. MSN LIFE SCIENCES PRIVATE LTD Company Information
Table 73. MSN LIFE SCIENCES PRIVATE LTD Introduction and Business Overview
Table 74. MSN LIFE SCIENCES PRIVATE LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 75. MSN LIFE SCIENCES PRIVATE LTD Edoxaban Tosylate API Product Offerings
Table 76. MSN LIFE SCIENCES PRIVATE LTD Recent Development
Table 77. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Company Information
Table 78. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Introduction and Business Overview
Table 79. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 80. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Edoxaban Tosylate API Product Offerings
Table 81. ZHEJIANG SUPOR PHARMACEUTICALS CO LTD Recent Development
Table 82. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Company Information
Table 83. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Introduction and Business Overview
Table 84. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 85. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Edoxaban Tosylate API Product Offerings
Table 86. SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO LTD Recent Development
Table 87. Simcere Pharmaceutical Company Information
Table 88. Simcere Pharmaceutical Introduction and Business Overview
Table 89. Simcere Pharmaceutical Edoxaban Tosylate API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
Table 90. Simcere Pharmaceutical Edoxaban Tosylate API Product Offerings
Table 91. Simcere Pharmaceutical Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Edoxaban Tosylate API Downstream Customers
Table 95. Edoxaban Tosylate API Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Edoxaban Tosylate API Product Picture
Figure 2. Global Edoxaban Tosylate API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Edoxaban Tosylate API Sales Volume (2019-2030) & (Tons)
Figure 5. Global Edoxaban Tosylate API Sales Price (2019-2030) & (US$/Ton)
Figure 6. Edoxaban Tosylate API Report Years Considered
Figure 7. Global Edoxaban Tosylate API Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Edoxaban Tosylate API Players Sales Volume Ranking (2023) & (Tons)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Edoxaban Tosylate API Revenue in 2023
Figure 10. Edoxaban Tosylate API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Purity≥98% Picture
Figure 12. Purity<98% Picture
Figure 13. Global Edoxaban Tosylate API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 14. Global Edoxaban Tosylate API Sales Value Market Share by Type, 2023 & 2030
Figure 15. Global Edoxaban Tosylate API Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
Figure 16. Global Edoxaban Tosylate API Sales Volume Market Share by Type, 2023 & 2030
Figure 17. Global Edoxaban Tosylate API Price by Type (2019-2030) & (US$/Ton)
Figure 18. Product Picture of Tablet
Figure 19. Product Picture of Others
Figure 20. Global Edoxaban Tosylate API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 21. Global Edoxaban Tosylate API Sales Value Market Share by Application, 2023 & 2030
Figure 22. Global Edoxaban Tosylate API Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
Figure 23. Global Edoxaban Tosylate API Sales Volume Market Share by Application, 2023 & 2030
Figure 24. Global Edoxaban Tosylate API Price by Application (2019-2030) & (US$/Ton)
Figure 25. North America Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 26. North America Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 27. Europe Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 28. Europe Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 29. Asia Pacific Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 30. Asia Pacific Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 31. South America Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 32. South America Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 33. Middle East & Africa Edoxaban Tosylate API Sales Value (2019-2030) & (US$ Million)
Figure 34. Middle East & Africa Edoxaban Tosylate API Sales Value by Country (%), 2023 VS 2030
Figure 35. Key Countries/Regions Edoxaban Tosylate API Sales Value (%), (2019-2030)
Figure 36. Key Countries/Regions Edoxaban Tosylate API Sales Volume (%), (2019-2030)
Figure 37. United States Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 38. United States Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 39. United States Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 40. Europe Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 41. Europe Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 42. Europe Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 43. China Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 44. China Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 45. China Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 46. Japan Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 47. Japan Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 48. Japan Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 49. South Korea Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 50. South Korea Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 51. South Korea Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 52. Southeast Asia Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 53. Southeast Asia Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 54. Southeast Asia Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 55. India Edoxaban Tosylate API Sales Value, (2019-2030) & (US$ Million)
Figure 56. India Edoxaban Tosylate API Sales Value by Type (%), 2023 VS 2030
Figure 57. India Edoxaban Tosylate API Sales Value by Application (%), 2023 VS 2030
Figure 58. Edoxaban Tosylate API Industrial Chain
Figure 59. Edoxaban Tosylate API Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Digital Multifunction Meter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
Whole Current Energy Meter - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
High Current Air Circuit Breaker - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Oct 12, 24
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232